Katja Zerbe
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 4
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 17
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 17
- Microbiology top 5%
- Antimicrobial Peptides and Activities 3
- Molecular Biology top 10%
- Chemical Synthesis and Analysis 9
- RNA and protein synthesis mechanisms 7
- Cancer therapeutics and mechanisms 5
-
- Bacterial Genetics and Biotechnology 5
-
- Bacteriophages and microbial interactions 3
- Co-authors
- John A. RobinsonFrancesca VitaliKatharina WoitheDong Bo LiKerstin MoehleLaurent BiglerLeo EberlIlme Schlichting
- Cited by
- Molecular MedicinePharmacology
- Journals
- Angewandte Chemie International Edition (3 papers)Journal of Biological Chemistry (3 papers)Organic & Biomolecular Chemistry (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Katja Zerbe
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Molecular Medicine 188
- Pharmacology 607
- Pharmacology 202
- Microbiology 140
- Molecular Biology 756
Countries citing papers authored by Katja Zerbe
This map shows the geographic impact of Katja Zerbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Zerbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Zerbe more than expected).
Fields of papers citing papers by Katja Zerbe
This network shows the impact of papers produced by Katja Zerbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Zerbe. The network helps show where Katja Zerbe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katja Zerbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 8 | |
| 2 | 2020 | 17 | |
| 3 | 2018 | 119 | |
| 4 | 2018 | 73 | |
| 5 | 2018 | 25 | |
| 6 | 2018 | 9 | |
| 7 | 2015 | 89 | |
| 8 | 2012 | 85 | |
| 9 | 2012 | 30 | |
| 10 | 2010 | 4 | |
| 11 | 2009 | 7 | |
| 12 | 2008 | 29 | |
| 13 | 2007 | 34 | |
| 14 | 2007 | 117 | |
| 15 | 2006 | 71 | |
| 16 | 2004 | 113 | |
| 17 | 2004 | 22 | |
| 18 | 2003 | 23 | |
| 19 | 2003 | 77 | |
| 20 | 2002 | 134 |
About Katja Zerbe
Katja Zerbe is a scholar working on Pharmacology, Molecular Medicine and Microbiology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Chemical Synthesis and Analysis (9 papers), RNA and protein synthesis mechanisms (7 papers), Cancer therapeutics and mechanisms (5 papers), Bacterial Genetics and Biotechnology (5 papers), Antibiotic Resistance in Bacteria (4 papers), Bacteriophages and microbial interactions (3 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Molecular Medicine (188 citations), Pharmacology (607 citations) and Pharmacology (202 citations). Katja Zerbe has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include John A. Robinson, Francesca Vitali, Katharina Woithe, Dong Bo Li, Kerstin Moehle, Laurent Bigler, Leo Eberl, Ilme Schlichting, Olena Pylypenko and M. Heck. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Biological Chemistry, Organic & Biomolecular Chemistry, ACS Medicinal Chemistry Letters and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.